Skip to main content
Caplight Logo









Orbis Diagnostics

Orbis Diagnostics

Private
AucklandHealthcare & Life Scienceshttps://www.orbisdiagnostics.com/

Last Round

VC Round

May 30, 2025

Total Funding Raised

$3.67M

Company Overview

Orbis Diagnostics is a healthtech company that is developing a point-of-care diagnostics platform capable of delivering clinically-accurate blood test results from a single fingerstick of blood.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticsPOCTlab-on-a-discrapid blood testingmicrofluidic technologyquantitative immunoassaydiagnostic platformimmunity testingMedTechmultiplex testingbiomarker analysisdiagnostic consumablesanimal health diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbis Diagnostics Comparables

Compare Orbis Diagnostics with similar companies based on industry and business-model similarity.

Orbis Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Truvian
87%
biosurfit
82%
Soulbrain Holdings Co. Ltd
77%

Orbis Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 30, 2025
GrantAug 1, 2024
SeedMay 20, 2022
Series ANov 16, 2021
VC RoundOct 12, 2020

Key People

Founding team and executive leadership

Cather Simpson

Chief Executive Officer

Executive Team

Orbis Diagnostics Investors

Notable investors and investment history

Orbis Diagnostics investors
InvestorRounds
Callaghan InnovationGrant
Even CapitalSeed, Series A
Booster Innovation FundSeed
Pacific ChannelVC Round, Series A
Clare VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Mar 19, 2026

    Grew 19% QoQ, from 16 to 19 employees.

Orbis Diagnostics Filings

Explore SEC and related filing metadata, where available.

Orbis Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orbis Diagnostics's valuation, stock price, and market status.

Is Orbis Diagnostics a public or private company?

Orbis Diagnostics is a private company.

What is the current stock price of Orbis Diagnostics?

Orbis Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Orbis Diagnostics worth (valuation)?

Valuation information for Orbis Diagnostics is not publicly available.

Can I buy Orbis Diagnostics stock?

Orbis Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orbis Diagnostics's last funding round?

Funding round information for Orbis Diagnostics is not publicly available.

Who are the main investors in Orbis Diagnostics?

Investor information for Orbis Diagnostics is not publicly disclosed.

Will Orbis Diagnostics IPO soon?

No public IPO plans have been announced for Orbis Diagnostics.

How can I track Orbis Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orbis Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAuckland
Employee Range16
Year Founded2016
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?